longecity foxo4 dri FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice FOXO4-DRI part 1 , #peptide

Animal models, predominantly rat Achilles tendon studies, demonstrate that BPC-157 significantly shortens healing time relative to untreated controls, with histological analysis showing improved collagen fiber organization at the injury site

Number of cycles A cycle is a defined treatment period with a protocol length that varies by peptide: CJC/Ipamorelin and Tesamorelin run 12-week (3-month) cycles, the Wolverine Stack (BPC-157/TB-500) runs on a 3-months-on, 2-months-off schedule, and GHK-Cu runs 30-day cycles

Front Pharmacol 15:1439536

Headaches or Lightheadedness: A small number of people might report mild headaches or feel a bit lightheaded for a short time, particularly right after an injection